Cyclacel Pharmaceuticals, Inc. Business Operations Contracts & Agreements
12 Contracts & Agreements
- Agency Agreements (4 contracts)
- Collaboration Agreements (4)
- Indemnification Agreements (2)
- Sales Agreements (1)
- Supply Agreements (1)
- Form of Placement Agency Agreement (Filed With SEC on April 19, 2024)
- Placement Agency Agreement by and between the Company and Ladenburg Thalmann & Co. Inc., dated December 21, 2023 (Filed With SEC on December 26, 2023)
- Form of Indemnification Agreement for directors (Filed With SEC on March 8, 2023)
- Controlled Equity Offering Sales Agreement, dated as of August 12, 2021, by and among Cyclacel Pharmaceuticals, Inc. and Cantor Fitzgerald & Co (Filed With SEC on August 12, 2021)
- Co-Placement Agency Agreement, by and among Cyclacel Pharmaceuticals, Inc., Roth Capital Partners, LLC, Ladenburg Thalmann & Co. Inc., and Brookline Capital Markets, a division of... (Filed With SEC on April 24, 2020)
- Form of Co-Placement Agency Agreement (Filed With SEC on April 14, 2020)
- Clinical Collaboration Agreement, dated October 1, 2018, by and between Cyclacel Pharamceuticals, Inc. and The University of Texas MD Anderson Cancer Center (Filed With SEC on November 13, 2018)
- SUPPLY AGREEMENT (Filed With SEC on May 16, 2005)
- COLLABORATION AGREEMENT (Filed With SEC on March 9, 2004)
- COLLABORATION AGREEMENT (Filed With SEC on March 3, 2004)
- COLLABORATION AGREEMENT (Filed With SEC on February 17, 2004)
- INDEMNIFICATION AGREEMENT (Filed With SEC on October 10, 2003)
